BRPI0919759A2 - polipeptídeos para tratamento e prevenção de adesões - Google Patents

polipeptídeos para tratamento e prevenção de adesões

Info

Publication number
BRPI0919759A2
BRPI0919759A2 BRPI0919759A BRPI0919759A BRPI0919759A2 BR PI0919759 A2 BRPI0919759 A2 BR PI0919759A2 BR PI0919759 A BRPI0919759 A BR PI0919759A BR PI0919759 A BRPI0919759 A BR PI0919759A BR PI0919759 A2 BRPI0919759 A2 BR PI0919759A2
Authority
BR
Brazil
Prior art keywords
polypeptides
prevention
adhesion treatment
adhesion
treatment
Prior art date
Application number
BRPI0919759A
Other languages
English (en)
Portuguese (pt)
Inventor
Panitch Alyssa
Original Assignee
Moerae Matrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Moerae Matrix Inc filed Critical Moerae Matrix Inc
Publication of BRPI0919759A2 publication Critical patent/BRPI0919759A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
BRPI0919759A 2008-10-20 2009-10-20 polipeptídeos para tratamento e prevenção de adesões BRPI0919759A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10683408P 2008-10-20 2008-10-20
PCT/US2009/061345 WO2010065206A1 (en) 2008-10-20 2009-10-20 Polypeptide for treating or preventing adhesions

Publications (1)

Publication Number Publication Date
BRPI0919759A2 true BRPI0919759A2 (pt) 2017-03-21

Family

ID=42108870

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0919759A BRPI0919759A2 (pt) 2008-10-20 2009-10-20 polipeptídeos para tratamento e prevenção de adesões

Country Status (11)

Country Link
US (1) US9034815B2 (cg-RX-API-DMAC7.html)
EP (1) EP2349310B1 (cg-RX-API-DMAC7.html)
JP (1) JP5785085B2 (cg-RX-API-DMAC7.html)
KR (2) KR101884616B1 (cg-RX-API-DMAC7.html)
CN (1) CN102256613B (cg-RX-API-DMAC7.html)
AU (1) AU2009322865B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0919759A2 (cg-RX-API-DMAC7.html)
CA (1) CA2741302C (cg-RX-API-DMAC7.html)
DK (1) DK2349310T3 (cg-RX-API-DMAC7.html)
ES (1) ES2507496T3 (cg-RX-API-DMAC7.html)
WO (1) WO2010065206A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2155228T3 (da) * 2007-01-10 2014-07-07 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
WO2009021137A2 (en) 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
ES2685505T3 (es) 2008-12-10 2018-10-09 Purdue Research Foundation Inhibidor de cinasas basado en péptidos de permeación celular
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US20110288036A1 (en) * 2010-05-24 2011-11-24 Cynthia Lander Methods for Treating or Preventing Vascular Graft Failure
US9890200B2 (en) 2011-04-12 2018-02-13 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
US9642888B2 (en) * 2011-04-12 2017-05-09 Moerae Matrix, Inc. Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
BR112014023068B1 (pt) * 2012-03-23 2022-03-03 Amicrobe, Inc Composição aquosa para prevenir, inibir ou tratar infecção e respectivo uso
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
WO2016061145A1 (en) * 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
SG11201703939XA (en) * 2014-11-17 2017-06-29 Moerae Matrix Inc Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
HK1246807A1 (zh) * 2015-01-08 2018-09-14 Moerae Matrix, Inc. Mk2抑制剂肽的制剂
CN107921082A (zh) 2015-03-12 2018-04-17 莫伊莱麦屈克斯公司 含有mk2抑制剂肽的组合物用于治疗非小细胞肺癌的用途
CN110740744A (zh) 2017-04-06 2020-01-31 艾麦克罗比公司 性能和安全性增强的局部施用的抗微生物剂的组合物和应用
RU2741247C1 (ru) * 2020-10-13 2021-01-22 федеральное государственное бюджетное образовательное учреждение высшего образования "Ростовский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО РостГМУ Минздрава России) Способ профилактики перитонеальных спаек женского таза

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521000A (en) * 1975-06-13 1978-08-09 Syntex Puerto Rico Inc Inhalation device
US4227522A (en) * 1978-09-05 1980-10-14 Syntex Puerto Rico, Inc. Inhalation device
US4192309A (en) * 1978-09-05 1980-03-11 Syntex Puerto Rico, Inc. Inhalation device with capsule opener
FR2550452B1 (fr) * 1982-10-08 1992-05-22 Glaxo Group Ltd Dispositif pour administrer des medicaments a des patients
US4778054A (en) * 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
FI88112C (fi) * 1985-07-30 1993-04-13 Glaxo Group Ltd Anordning foer administrering av laekemedel till patienter
JPH05963A (ja) 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
AU4115693A (en) 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
US6582728B1 (en) * 1992-07-08 2003-06-24 Inhale Therapeutic Systems, Inc. Spray drying of macromolecules to produce inhaleable dry powders
ES2149962T3 (es) * 1993-12-09 2000-11-16 Univ Jefferson Compuestos y metodos para mutaciones dirigidas al sitio en celulas eucarioticas.
AU2003260668A1 (en) * 2002-04-01 2003-10-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Biological affinity based delivery systems
EP1824336A4 (en) * 2004-12-02 2009-10-14 Univ North Carolina INHIBITION OF PHOSPHORYLATION HSP27 TO TREAT VESICATION DISORDERS
CN101232895B (zh) * 2005-04-15 2014-06-04 亚利桑那癌症治疗公司 用于治疗转移性癌症的治疗肽
US20080293640A1 (en) * 2007-01-10 2008-11-27 Arizona Board of Regents, A body Corporate, of the State of Arizona, acting for and on behalf of Polypeptide inhibitors of HSP27 kinase and uses therefor
DK2155228T3 (da) * 2007-01-10 2014-07-07 Purdue Research Foundation Polypeptidinhibitorer af HSP27-kinase og anvendelser herfor
WO2008109794A2 (en) * 2007-03-08 2008-09-12 Tufts Medical Center The role of the mk2 pathway in treating fibrosis and scarring
WO2009021137A2 (en) * 2007-08-07 2009-02-12 Purdue Research Foundation Kinase inhibitors and uses thereof
US20090269406A1 (en) * 2008-04-02 2009-10-29 Alyssa Panitch Therapeutic uses of biocompatible biogel compositions

Also Published As

Publication number Publication date
KR20110095867A (ko) 2011-08-25
WO2010065206A1 (en) 2010-06-10
US9034815B2 (en) 2015-05-19
KR101884616B1 (ko) 2018-08-06
ES2507496T3 (es) 2014-10-15
CA2741302C (en) 2017-02-28
AU2009322865B2 (en) 2013-07-18
KR20170001756A (ko) 2017-01-04
CN102256613A (zh) 2011-11-23
AU2009322865A1 (en) 2010-06-10
JP5785085B2 (ja) 2015-09-24
EP2349310A1 (en) 2011-08-03
DK2349310T3 (da) 2014-08-11
EP2349310B1 (en) 2014-07-23
CN102256613B (zh) 2014-09-10
JP2012506442A (ja) 2012-03-15
EP2349310A4 (en) 2012-11-21
US20130101671A9 (en) 2013-04-25
US20100098760A1 (en) 2010-04-22
CA2741302A1 (en) 2010-06-10

Similar Documents

Publication Publication Date Title
BRPI0919759A2 (pt) polipeptídeos para tratamento e prevenção de adesões
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0917089A2 (pt) métodos e sistemas planos de ação personalizados
BRPI0809978A2 (pt) Dispositivos e métodos de dispensação de gotículas
BRPI0820379A2 (pt) Sistemas e métodos de dispensação de produto médico
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
BRPI0806964A2 (pt) Combinações de agonístico beta-2-adrenoceptor e benzotiazolona
IL207096A0 (en) Modified leptin polypeptides and their uses
DK2405869T3 (da) Fedmebehandling
BR112012004281A2 (pt) uso de metformina tratamento e prevenção de câncer
BRPI0910259A2 (pt) métodos de tratamento de inflamação
BRPI1015379A2 (pt) sistemas de cálculo biométrico e métodos
BRPI0908379A2 (pt) sistemas e métodos para obter dentaduras customizadas
BRPI1016199A2 (pt) cobertura de ferimento e kit de tratamento de ferimentos.
BRPI0917288A2 (pt) sensor de biomems e aparelhos e métodos para o mesmo
HUE059436T2 (hu) PSMA-kötõ szerek és alkalmazásaik
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
EP2476717A4 (en) POLYAMIDE AND POLYAMIDE COMPOSITION
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
EP2209114A4 (en) ENCODER AND DECODER
BRPI0816789A2 (pt) Goji e inflamação
BRPI0811870A2 (pt) Tratamento e prevenção de influenza
EP2141105A4 (en) SPLICE HEAD, SPLICE DEVICE, AND SPLICE METHOD
HRP20160577T1 (hr) Liječenje osteoartritisa
BRPI0816288A2 (pt) Processos e compostos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL